Elmiron Settlement Conference Scheduled Following Resolution of “Substantial Portion” of Vision Damage Lawsuits
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Elmiron Lawyers to Meet with MDL Judge Via Zoom For Initial Case Management Conference January 4, 2021 Irvin Jackson Add Your Comments After the U.S. Judicial Panel on Multidistrict Litigation (JPML) decided last month to consolidate and centralize all Elmiron vision loss lawsuits filed throughout the federal court system, the U.S. District Judge appointed to preside over the pretrial proceedings has scheduled an initial conference for January 8, to meet virtually through Zoom with lawyers involved in the litigation. Elmiron (pentosan polysulfate sodium or PPS) is a prescription medication that has been on the market since 1996, as a treatment for the painful bladder condition known as interstitial cystitis. However, in recent months, the drug makers have faced a growing number of product liability lawsuits brought by users left with permanent vision problems and retina damage, including difficulty adapting in dark light, spots or floaters in the vision, as well as blindness. Each of the claims raise similar questions of fact and law, over the link between Elmiron and vision problems, known as pigmentary maculopathy, as well as whether Johnson & Johnson and its Janssen Pharmaceuticals subsidiary withheld warnings and information about the importance of monitoring long-term users of the medication. ELMIRON LAWSUITS Did you or a loved one use Elmiron? Side effects of Elmiron have been linked to vision loss and retinal damage known as pigmentary maculopathy. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ELMIRON LAWSUITS Did you or a loved one use Elmiron? Side effects of Elmiron have been linked to vision loss and retinal damage known as pigmentary maculopathy. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Following new warnings required by federal regulators last year, about 100 product liability lawsuits have already been filed in U.S. District Courts nationwide. However, as Elmiron lawyers continue to investigate and file potential claims over the coming months and years, it is widely expected that several thousand cases will be brought throughout the federal court system. To reduce duplicative discovery into common issues in the cases, avoid conflicting pretrial rulings from different courts and serve the convenience of common witnesses, parties and the judicial system, the U.S. JPML issued an order last month transferring all Elmiron cases to the District of New Jersey, where U.S. District Judge Brian R. Martinotti will preside over coordinated pretrial proceedings. In a case management order (PDF) issued on December 18, Judge Martinotti outlined the early steps in organizing the proceedings and indicated that an initial case management conference will be held on January 8, via a Zoom videoconference, in order to maintain safety precautions amid the ongoing COVID-19 pandemic. Judge Martinotti ordered lawyers involved in Elmiron litigation to meet and confer before the conference in order to achieve as much consensus as possible on a proposed discovery plan, suggested schedule for joinder of parties, as well as other items on the agenda. He also called on plaintiffs and defendants’ attorneys to submit a brief written statement, of no more than three pages, on their preliminary understanding of the faces involved in the litigation as well as “critical factual and legal issues.” Those statements will not be considered binding by the court. As part of the coordinated management, Judge Martinotti is expected to appoint a small group of Elmiron lawyers to serve in various leadership positions during the coordinated proceedings, taking actions that benefit all plaintiffs during discovery, hearings and a series of early bellwether trials that will be scheduled to help gauge how juries are likely to respond to the evidence and testimony that will be repeated throughout the litigation. Following the coordinated proceedings in the federal multidistrict litigation (MDL), if Elmiron vision settlements or another resolution for the litigation is not reached, the claims may later be remanded back to U.S. District Courts nationwide for individual trial dates in future years. Tags: Elmiron, Interstitial Cystitis, Janssen, Pigmentary Maculopathy, Vision Loss More Elmiron Lawsuit Stories Elmiron Settlement Conference Scheduled Following Resolution of “Substantial Portion” of Vision Damage Lawsuits January 26, 2024 Nearly 2,000 Elmiron Eye Damage Lawsuits Pending in State and Federal Courts November 7, 2022 Elmiron Jury Trial Over Vision Loss Delayed Until March 2023 October 26, 2022 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Elmiron Settlement Conference Scheduled Following Resolution of “Substantial Portion” of Vision Damage Lawsuits January 26, 2024
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)